Entolimod for Vaccine Augmentation

Trial Profile

Entolimod for Vaccine Augmentation

Phase of Trial: Phase 0

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Entolimod (Primary) ; Diphtheria-tetanus vaccine
  • Indications Drug abuse
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Mar 2018 Planned End Date changed from 1 Apr 2018 to 1 Dec 2019.
    • 16 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 12 Nov 2017 Planned End Date changed from 1 Jun 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top